OVAGE
RUO
20mg
pep-OVA-20mg-us
Ovagen
$75.34Out of stock
Loading product…
RUO
20mg
pep-CBL-20mg-us
CBL-514 20mg
CBL-514 is a synthetic small molecule studied for its interaction with the adipocyte apoptosis pathway in localized adipose tissue, distinct from surgical and energy-based approaches under research. Goodman et al. (Aesthetic Surgery Journal, 2022; PMID 35709509) conducted a phase IIa study measuring ultrasound-based localized fat volume across three treatment-level groups as pharmacodynamic endpoints. For Research Use Only. Not for human consumption.
$150.14Out of stock
1
For laboratory research use only · Not for human or veterinary use.
Description
About this peptide
About This Compound
CBL-514 is a synthetic small molecule studied for its interaction with the adipocyte apoptosis pathway in localized adipose tissue. It has been characterized in the literature as a lipolytic agent under clinical investigation, distinct from surgical and energy-based fat-reduction approaches. The way a scheduled demolition targets a single structure while leaving surrounding buildings intact, CBL-514 is described in research as triggering programmed cell death selectively within targeted adipocyte populations in the treated tissue region.
Research Context
Goodman et al. (Aesthetic Surgery Journal, 2022; PMID 35709509) conducted a phase IIa, open-label study of CBL-514 administered into the abdominal adipose layer, using ultrasound to measure localized fat volume and thickness across three treatment-level groups as endpoints for characterizing the adipocyte-apoptosis pharmacodynamic profile. Gold et al. (Aesthetic Surgery Journal, 2025; PMID 40037659) conducted a randomized, single-blind, placebo-controlled phase 2 trial of CBL-514, examining ultrasound-measured localized fat-volume thresholds and safety observations across treatment and placebo arms. Carrion et al. (Plastic and Reconstructive Surgery, 2025; PMID 41296813) included CBL-514 among the lipolytic agents examined in a systematic review of clinical literature on localized-adiposity treatment approaches, summarizing study designs, endpoints, and comparative pharmacology across the reviewed compounds.
Research Use Disclaimer
For Research Use Only. Not for human consumption.
Specifications
At a glance
- SKU
- pep-CBL-20mg-us
- Strength
- 20mg
- Form
- Lyophilized powder
- Storage
- −20 °C, protected from light
- COA
- Per lot, on file
- Availability
- Out of stock
Shipping & Storage
Handling this material
Shipping
Orders ship within 24 hours. Delivered via USPS Priority or standard FedEx unless expedited shipping is selected at checkout. Tracking is emailed on dispatch and mirrored in your account.
In-transit handling
Lyophilized vials are shelf-stable and ship at ambient temperature. Storage in our warehouse is cooled; shipment does not require refrigeration.
Long-term storage
Lyophilized vials are shelf-stable at ambient temperature; refrigeration (2–8°C) extends shelf life. Refer to the batch-specific Certificate of Analysis for material-specific storage guidance. Once reconstituted, follow the storage instructions on the batch COA. Not for human or animal consumption.
Returns
Because these are research-grade biologics, we cannot accept returns on opened vials. Damaged-in-transit shipments are replaced at no cost within 7 days of delivery.
Frequently asked
Common questions
No. Every SKU is labeled and sold strictly for laboratory research use only. These are not drugs, dietary supplements, or veterinary products. Research Use Only policy
Related
